Key Events This Week
7 Sep: Sharp 4.26% decline amid technical momentum shift
8 Sep: Downgrade to Hold by MarketsMOJO following mixed signals
9 Sep: Strong rebound of 4.91% despite Sensex weakness
11 Sep: Week closes with a 0.67% gain at Rs.437.15
Sep 22, 03:30 PM
BSE+NSE Vol: 19.75 k

Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 8 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news article
7 Sep: Sharp 4.26% decline amid technical momentum shift
8 Sep: Downgrade to Hold by MarketsMOJO following mixed signals
9 Sep: Strong rebound of 4.91% despite Sensex weakness
11 Sep: Week closes with a 0.67% gain at Rs.437.15

Titan Biotech Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating downgraded from Buy to Hold as of 8 September 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to deliver strong quarterly results and impressive returns over recent years, concerns around valuation premiums and mixed technical signals have tempered enthusiasm among analysts.
Read full news article
Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent price decline of 4.26% to ₹415.55, the company’s long-term returns remain robust, prompting a recent upgrade in its Mojo Grade from Hold to Buy.
Read full news article
31 Aug: Stock dips 1.63% amid broader market weakness
1 Sep: Sharp rebound with 5.00% gain despite Sensex decline
2 Sep: Continued strong rally, up 5.00% on heavy volume
3 Sep: Gains of 4.91% as technical momentum improves
4 Sep: Rating upgraded to Buy; stock closes slightly down at Rs.434.05 (-0.26%)

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating upgraded from Hold to Buy by MarketsMOJO as of 3 September 2026. This upgrade reflects a marked improvement across key parameters including technical indicators, financial trends, valuation metrics, and overall quality assessment, signalling renewed investor confidence in the company’s prospects.
Read full news article
Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling a potential upward trajectory for the stock amid strong relative performance against the broader market.
Read full news article
Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 August 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 August 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleNotice of Loss of Share Certificate-Disclosure under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulations 2015
Newspaper Publication regarding Notice of 34th Annual General Meeting E-Voting and other related information
Notice of 34th Annual General Meeting of the Company scheduled to be held on Tuesday September 29 2026 at 03:00 P.M.(IST) through VC/OAVM
No Upcoming Board Meetings
Titan Biotech Ltd has declared 25% dividend, ex-date: 22 Sep 26
Titan Biotech Ltd has announced 2:10 stock split, ex-date: 20 Feb 26
No Bonus history available
No Rights history available